Cart
sales@molnova.com
Yadanzioside G
CAS No. 95258-17-6
Yadanzioside G( —— )
Catalog No. M31503 CAS No. 95258-17-6
Yadanzioside G has antileukemic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 969 | In Stock |
|
| 5MG | 637 | In Stock |
|
| 10MG | 905 | In Stock |
|
| 25MG | 1349 | In Stock |
|
| 50MG | 1786 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameYadanzioside G
-
NoteResearch use only, not for human use.
-
Brief DescriptionYadanzioside G has antileukemic activity.
-
DescriptionYadanzioside G has antileukemic activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number95258-17-6
-
Formula Weight768.76
-
Molecular FormulaC36H48O18
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
proFIX18
proFIX18
-
Hederagenin-28-beta-...
Hederagenin 28-O-beta-D-glucopyranosyl ester, a triterpenoid saponin isolated from Ilex cornuta, exhibits protective effects against H2O2-induced myocardial cell injury.
-
PACAP (6-38), human,...
PACAP (6-38), human, ovine, rat TFA is a potent PACAP receptor antagonist with IC50s of 30, 600, and 40 nM for PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2, respectively.
